Connect with us

Business

Johnson & Johnson vaccine hits production snags – POLITICO

The company could seek emergency authorization from FDA this month, but supplies may be thin at first.

Published

on

post featured image
ADVERTISEMENT

A Johnson & Johnson spokesperson declined to confirm the delay, but said the company remains “confident in our ability to meet our 2021 supply commitments.”
“We remain in active discussions with regulators, including on the approval and validation of our manufacturing processes,” the spokesperson said.
“Operation Warp Speed is working with Johnson & Johnson to scale up and maximize manufacturing of the Janssen vaccine,” an HHS spokesperson said. “Making projections at this time is premature.”
Warp…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

post featured image
Bill Gates Is Now the Largest Farmland Owner in America – HYPEBEAST
Oil-Rich Abu Dhabi Targets Hydrogen as Future Export Fuel – Bloomberg
post featured image
Top Tech Stocks for 2021 – Motley Fool